首页> 美国卫生研究院文献>other >Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant glioma

【2h】

Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant glioma

机译：渗透性血糖中渗透性肺瘤渗透血脑屏障破坏后贝伐单抗的超重耐受性和最大耐受剂量

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

ObjectThe authors assessed the safety and maximum tolerated dose of superselective intraarterial cerebral infusion (SIACI) of bevacizumab after osmotic disruption of the blood-brain barrier (BBB) with mannitol in patients with recurrent malignant glioma.

著录项

期刊名称 other
作者
John A. Boockvar; Apostolos J. Tsiouris; Christoph P. Hofstetter; Ilham I Kovanlikaya; Sherese Fralin; Kartik Kesavabhotla; Stephen M. Seedial; Susan C. Pannullo; Theodore H. Schwartz; Philip Stieg; Robert D. Zimmerman; Jared Knopman; Ronald J. Scheff; Paul Christos; Shankar Vallabhajosula; Howard A. Riina;
展开▼
作者单位

展开▼
年(卷),期 -1(114),3
年度 -1
页码 624–632
总页数 17
原文格式 PDF
正文语种
中图分类
关键词
bevacizumab glioma brain neoplasm intraarterial infusion mannitol;

机译：贝伐单抗;神经胶质瘤;脑肿瘤;动脉内输注;甘露醇;

相似文献

外文文献
中文文献
专利

1. Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant glioma. [J] . Boockvar JA, Tsiouris AJ, Hofstetter CP, Journal of neurosurgery. . 2011 ,第3期

机译：渗透性血脑屏障破坏后复发性恶性神经胶质瘤的贝伐单抗超选择性动脉内脑输注贝伐单抗的安全性和最大耐受剂量。
2. Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant glioma. [J] . Boockvar JA, Tsiouris AJ, Hofstetter CP, Journal of neurosurgery. . 2011 ,第3期

机译：渗透血脑阻隔后渗透性恶性胶质瘤渗透血糖破坏后贝伐单抗的安全性和最大耐受剂量。
3. Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant glioma. [J] . Boockvar JA, Tsiouris AJ, Hofstetter CP, Journal of neurosurgery. . 2011 ,第3期

机译：渗透血脑阻隔后渗透性恶性胶质瘤渗透血糖破坏后贝伐单抗的安全性和最大耐受剂量。
4. Targeted drug-loading microbubbles with focused ultrasound induced blood-brain barrier disruption for glioma treatment [C] . Chien-Yu Ting, Ching-Hsiang Fan, Hao-Li Liu, IEEE International Ultrasonics Symposium . 2012

机译：具有聚焦超声诱导的血脑屏障破坏胶质瘤治疗的靶向药物装载微泡
5. Balloon-Assisted Superselective Intra-Arterial Cerebral Infusion of Bevacizumab for Malignant Brainstem Glioma [O] . H.A. Riina, J. Knopman, J.P. Greenfield, 2010

机译：贝伐单抗球囊辅助超选择性动脉内输注治疗恶性脑干胶质瘤
6. Erratum to: Superselective intraarterial cerebral infusion of cetuximab after osmotic blood/brain barrier disruption for recurrent malignant glioma: phase I study [O] . Shamik Chakraborty, Christopher G. Filippi, Tamika Wong, 2016

机译：错误至：复发性恶性胶质瘤渗透血液/脑屏障破坏后西妥昔单抗的超出心脏内脑输注：I阶段研究

Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant glioma

摘要

著录项

相似文献

相关主题

期刊订阅